The expression of the cyclin-dependent kinase inhibitor p15 INK4B in normal cells after induction with TGF-b1, or following overexpression from an adenovirus-encoded cDNA, appears on an SDS-polyacrylamide gel as a doublet. Here, the underlying mechanism behind the synthesis of the two species has been studied. By expressing cDNAs truncated at their 5' end, we found that the synthesis of the more slowly migrating form, called p15.5
The expression of the cyclin-dependent kinase inhibitor p15 INK4B in normal cells after induction with TGF-b1, or following overexpression from an adenovirus-encoded cDNA, appears on an SDS-polyacrylamide gel as a doublet. Here, the underlying mechanism behind the synthesis of the two species has been studied. By expressing cDNAs truncated at their 5' end, we found that the synthesis of the more slowly migrating form, called p15.5
INK4B
, is dependent on a sequence upstream of the ®rst AUG codon thought to initiate translation of p15 INK4B . Two potential, in frame, alternative upstream initiation codons, ACG and GUG, were individually changed to GCA encoding alanine. Analysis by in vitro translation, or immunoblotting of lysates from transfected 293 cells, showed that translation of p15.5
INK4B is initiated at the GUG located 13 codons upstream of the ®rst AUG. When this AUG was mutated, p15
INK4B was no longer made. Instead, a shorter form, initiated at an in frame AUG located seven codons downstream, was synthesized. Finally, when both these AUGs were mutated, only p15.5 INK4B was generated. Both p15 INK4B and p15.5 INK4B bound to CDK4 and CDK6, inhibited DNA synthesis, and caused replicative senescence of a human glioma cell line. We thus conclude that p15 INK4B and p15.5
, encoded by the CDKN2B gene, are functionally indistinguishable as based on these assays. Oncogene (2000) 19, 1724 ± 1728.
Keywords: cell cycle control; cell cycle inhibitors; replicative senescence; non-AUG translation initiation During cell cycle progression, cyclin-dependent kinases (CDKs) are activated by sequentially binding to dierent cyclins. A negative control is exerted by a set of CDK inhibitors (CDKIs) (Hunter and Pines, 1994; Sherr, 1996) . The INK4-family of inhibitors  comprises p16   INK4A   , p15   INK4B   , p18   INK4C , and p19
INK4D
, all of which are speci®c for CDK4 and CDK6 (Sherr and Roberts, 1995; Sherr, 1996) . Binding of p16 INK4A (p16) or p15 INK4B (p15) to CDK4/6 prevents the formation of an active cyclin D-CDK complex in the G1 phase (Hall et al., 1995) .
The CDKIs have attracted much attention because of their potential as tumour suppressors. While the role of p16 as a tumour suppressor has been amply demonstrated, the role of p15 in tumorigenesis remains less well studied (Hall and Peters, 1996; Hunter and Pines, 1994; Sherr, 1996) . P15 was originally discovered as a protein strongly induced by TGF-b1 (Hannon and Beach, 1994) . Recently it was shown that it is also induced by interferon-a (IFN-a) (Sangfelt et al., 1997) . CDKN2B is frequently homozygously or heterozygously deleted together with CDKN2A in a variety of tumour cell lines and primary tumours (Hirama and Koeer, 1995) . Overexpression of p15 is able to block cell cycle progression in G1 (Arap et al., 1997; McConnell et al., 1998; Stone et al., 1995) . We have recently found that overexpression of p15 from an adenovirus vector, blocks cell proliferation, induces replicative senescence, and downregulates telomerase activity similarly to p16 (Fuxe et al., 2000 unpublished results) .
During the course of our studies on p15, we consistently observed that p15 migrates as a doublet on SDS-polyacrylamide gels. These two species, called p15.5 and p15, were already noted in the original report by Hannon and Beach (1994) describing p15, and has been observed subsequently also by others (Reynisdottir et al., 1995) . Since isoforms of various proteins may possess dierent functions, have dierent stability, or display dierent subcellular distribution, we set out to analyse the molecular and possible functional dierences between the two p15 isoforms.
When 293 cells were infected with a recombinant adenovirus encoding p15 (Ad5CMVp15) and the cell lysate analysed by SDS ± PAGE followed by immunoblotting with an anti-p15 antiserum, two closely spaced species (called p15 and p15.5, respectively) were observed ( Figure 1a , lane 2). In the cDNA used to construct the recombinant adenovirus, the ®rst AUG codon in the mRNA thought to initiate p15 translation was preceded by some 178 nontranslated nucleotides. The 5' noncoding region of the p15 mRNA was reported to be 327 nucleotides (Hannon and Beach, 1994) . To check that the two species did not arise due to the particular adenovirus construct used, we also analysed p15 from TGF-b1-induced HaCaT keratinocyte cells (Hannon and Beach, 1994) . Both p15.5 and p15 were evident in uninduced cells (Figure 1a , lane 3), and both were upregulated by TGF-b1 (lane 4). Finally, p15.5 and p15 were also observed after in vitro translation (lane 5).
There are several ways of generating isoforms of proteins, translation from alternatively spliced mRNAs, proteolytic processing, or posttranslational modi®cations being three possibilities. In addition, a commonly used mechanism is initiation of translation from codons other than the classical AUG (e.g. ACG, CUG, or GUG) (Kozak, 1991) . In preliminary experiments, our initial hypothesis that p15.5 and p15 are initiated from the two in frame AUG codons spaced six codons apart (Figure 1b ) turned out to be incorrect (see below). We therefore looked for other alternative initiation sites. To this end, progressive deletions of the 5' region just upstream of the ®rst AUG codon (position 328) ( Figure 1b) were made, and their ability to direct the synthesis of p15.5 and p15 was analysed. Complementary DNA constructs starting at positions 180 (pCR-P15), 265 (pCR-N62), 289 (pCR-N39), 307 (pCR-N21), and 322 (pP15; Tsubari et al., 1997) (numbering is according to Hannon and Beach, 1994) were transcribed and translated in vitro, and the resulting products analysed by immunoprecipitation and SDS ± PAGE. Messenger RNAs containing 178, 62 or 39 nucleotides upstream from the ®rst AUG codon all generated p15.5 and p15. In contrast, constructs pCR-N21 and pP15, having 21 and six nucleotides upstream of the AUG, respectively, gave rise only to p15 (data not shown).
Translation of p15.5 is initiated at a GUG codon upstream of the first AUG
The above results indicated that nucleotides around positions 285 ± 290 are crucial for p15.5 synthesis. In this region there are two codons at positions 286 (ACG) and 289 (GUG) (Figure 1b ) that have previously been shown to occasionally initiate translation. Further upstream (position 265), there is another in frame GUG codon, which we, however, considered an unlikely site for initiation, since p15.5 was still made from the pCR-N39 construct lacking this GUG codon. We next changed the two candidate initiation codons into GCA (pCR-P15:1 and pCR-P15:2) In a separate construct, the ®rst AUG was mutated to GCG (pCR-P15:3) ( Figure 2a ). The corresponding in vitro transcribed mRNAs were again ®rst translated in vitro. As seen in Figure 2b , the pCR-P15:1 mutant (lane 1) still yielded p15.5 and p15. The pCR-P15:2 mutant gave rise only to a weak p15.5 band (lane 2), while the pCR-P15:3 mutant yielded p15.5 and a faster migrating band (p13), but no p15 (lane 3). These results suggested that p15.5 might be initiated at the GUG codon.
As pointed out by Kozak (1989 Kozak ( , 1990 , the ®delity of translation initiation in cell-free systems is critically dependent on the conditions used. We therefore expressed the above constructs in U251 MG cells to control for a possible in vitro artifact. As shown in Figure 2c , the results were now even more clear-cut. While pCR-P15:1 gave rise to both isoforms (lane 2), pCR-P15:2 yielded only p15 (lane 3). pCR-P15:3 again gave rise to p15.5 and the new species p13 (lane 3). Since the most likely reason for the generation of p13 was initiation at the second, downstream, AUG codon (position 349; Figure 1b) , we also expressed the double mutant pCR-P15:4 (Figure 2a ) in U251 MG cells. As shown in lane 5, this mutant yielded only p15.5. Initiation at the GUG codon was clearly less ecient than at the ®rst AUG codon (lane 3).
From these results we conclude that p15.5 is initiated at a GUG codon located 13 codons upstream from the ®rst AUG.
Both p15.5 and p15 associate with CDK4 and CDK6, block DNA synthesis, and cause replicative senescence
We next analysed whether both p15.5 and p15 could associate with CDK4 and CDK6 as an indication that both isoforms are functional CDKIs. The proteins were expressed from the recombinant adenovirus vector in the glioma cell line U251MG, which has a homozygously deletion of the CDKN2A and CDKN2B genes and an intact RB-pathway (Fuxe et al., 2000 unpublished results) . Immunoblotting with anti-p15 antiserum of total lysate indicated the presence of both isoforms ( Figure 2d , lane 2). Immunoprecipitations with antisera against CDK4 or CDK6 followed by blotting with anti-p15 antiserum showed that both p15.5 and p15 readily associated with the CDKs (lanes 4 and 6). No p15.5 or p15 were observed in mock-infected cells (lanes 1, 3 and 5). We The 5' region of the human p15 cDNA, highlighting the sequence upstream and downstream of the classical ATG initiation codon at position 328. This ATG is followed by an additional in frame ATG at position 349. The 5' ends of the dierent progressively truncated constructs pCR-p15, -N62, -N39, -N21 and pP15 are marked with arrows. The alternative nonclassical initiation codons located upstream and in frame with the two ATG codons are shown in bold. Numbering of the nucleotide sequence is according to Hannon and Beach (1994) have repeatedly observed that p15.5 seem to bind more avidly to both CDK4 and CDK6 than p15 (compare lane 2 to lanes 4 and 6).
To analyse whether both isoforms were able to inhibit DNA synthesis, we transfected U251MG cells with the plasmids pCR-P15 (synthesizes both p15.5 and p15), pCR-P15:4 (only p15.5), and pCR-P15:2 (only p15). DNA synthesis was monitored by the incorporation of bromodeoxyuridine (BrdUrd). Cells were double-stained for p15 and BrdUrd using speci®c antisera. If both p15 isoforms would be able to block DNA synthesis, then p15.5 or p15-positive cells would be unable to incorporate BrdUrd. The results from three independent experiments (Table 1), showed that singly expressed p15.5 and p15 were as ecient in blocking DNA synthesis (90 ± 95%), as was the combination of p15.5 and p15. Thus, we conclude that both isoforms are equally potent in blocking DNA synthesis and hence cell proliferation.
We (Fuxe et al., 2000 unpublished results) and others (McConnell et al., 1998) have recently shown that the combined overexpression of p15.5 and p15 causes a replicative senescent phenotype. We therefore analysed whether the two isoforms could cause this eect when expressed individually in U251MG cells. As shown in Figure 3 , cells expressing either both isoforms (b), p15 alone (d), or p15.5 alone (f), all had an enlarged and¯attened morphology and stained positive for the senescence-associated b-galactosidase (SA-bgal) marker enzyme, while mock-transfected cells were negative and displayed a normal morphology (h). To con®rm the expression of p15.5 and p15, cells were also analysed in parallel by immuno¯uorescence using the p15 antiserum (Figure 3a,c,e,g ). This showed that cells, transfected with either one of the three constructs, and displaying an enlarged and¯attened morphology, were positive for both SA-b-gal and p15 expression.
In conclusion, we show here that two isoforms, p15.5 and p15, encoded by the CDKN2B gene and members of the INK4-family of cyclin-dependent kinase inhibitors are synthesized from two alternative, in frame, translation initiation codons. While p15 was shown to be initiated at the ®rst AUG codon located 328 nucleotides from the 5' end, p15.5 was initiated at a GUG codon at position 289, which encodes valine. Thus p15.5 is an N-terminally extended form of p15. Both isoforms appeared, based on the assays used here, to be functionally indistinguishable.
According to the ribosome scanning model formulated by Kozak (1989) , the 40S ribosomal subunit scans the mRNA from the 5' cap towards the 3' end and assembles an 80S initiation complex at the ®rst AUG codon provided it has a favourable sequence context (see below). In a small number of vertebrate mRNAs, translation initiation may occur at a non-AUG codon (e.g. ACG, CUG, or GUG) located upstream at the ®rst AUG codon. Such initiation is usually inecient and occurs in addition to initiation at the ®rst AUG (for references, see Kozak, 1991) . Due to this leakiness at the alternative initiation codon, two (or more) products are synthesized. This is also the case in regard to p15.5/p15. The ratio of p15.5 to p15 varied between cell types and between experiments, but p15.5 was regularly made in lesser amounts than p15.
Based on the compilation of hundreds of vertebrate mRNAs, the consensus sequence GCC(A/ G)CCAUGG, i.e. a purine at position 73 (usually an A) and a G in position +4 (the A in AUG is designated +1), has emerged as optimal for initiation Figure 2 Mutational analysis of the alternative upstream initiation codons. (a) Schematic representation of the dierent mutants. Plasmid pCR-P15 was constructed by cloning of the p15 cDNA into the pCR3.1 vector (Invitrogen BV, NV Leek, The Netherlands). The mutant plasmids were made by single-stranded mutagenesis (Muta-Gene phagemid kit, Bio-Rad Laboratories GmbH, Munich, Germany), using the pCR-P15 plasmid DNA as template and oligonucleotide primers with dierent nucleotide substitutions. In the constructs pCR-P15:1 and pCR-P15:2, the alternative initiation codons at positions 286 (ACG) and 289 (GTG), respectively, were changed to GCA (Ala). In the construct pCR-P15:3, the classical ATG at position 328 was substituted by GCG (Ala), and in pCR-P15:4, the ATGs at positions 328 and 349 were both changed to GCG. (b) 35 Smethionine-labelled proteins were synthesized by in vitro transcription/translation and the products analysed on a 15% SDSpolyacrylamide gel. (c) Mutant forms of p15 were transiently expressed in the glioma cell line U251MG (obtained from the Department of Pathology, Uppsala University; NisteÂ r and Westermark, 1994) following transfection with 1 ± 2 mg of the indicated plasmids using 5 ± 10 ml of Lipofectamine TM (Life Technologies Inc., Scotland, UK). Total cell lysates were prepared and the p15 products analysed by immunoblotting following separation on a 15% SDS-gel. (d) Association of the p15 and p15.5 isoforms with CDK4 and CDK6. U251MG cells were infected with the p15-expressing adenovirus (Ad5CMVp15) at a multiplicity of infection of 50. After 48 h, total cell lysates from infected (lanes 2, 4 and 6) and mock-infected (lanes 1, 3 and 5) cells were prepared. Each lysate was divided into three samples. One sample was used to detect the isoforms by immunoblotting (lanes 1 and 2) , while the other two samples were ®rst subjected to immunoprecipitation with antisera against CDK4 (H22, Santa Cruz) or CDK6 (C21, Santa Cruz), followed by separation on a 15% SDS-gel, immunoblotting with anti-p15 antiserum (C-20, Santa Cruz) (lanes 3 ± 6), and visualization by ECL (Kozak, 1989) . The same rules also apply to initiation at the alternative codons (Kozak, 1991) . The context around the GUG codon initiating p15.5 synthesis (ACGGUGGAU) is very close to the Kozak consensus sequence with an A at position 73 and a G in position +4. In contrast, the sequence context around the ®rst AUG (GGAAUGCGA) and second AUG (GGCAUGCCC) (Figure 1b ) appears somewhat less favourable. Occasionally, a faint 13 kDa band was observed (e.g. Figure 1a , lanes 2 and 4). This species (p13) is probably initiated at the second AUG.
Initiation at non-AUG codons is also aected by the length and sequence of the 5' noncoding region. It has been shown that long 5' noncoding sequences, which are frequently quite GC-rich, may have a higher degree of secondary structure which in turn could result in a slowing down of the transit of the 40S ribosomal subunit down the mRNA. This may favour initiation at non-AUG codons (Kozak, 1990) . The 5' noncoding region of the p15 mRNA is unusually long (327 nucleotides) and also GC rich (65%). These characteristics could thus also contribute to the initiation at the GUG codon.
An N-terminal extension of proteins have in some cases been shown to aect the function and/or the fate of the protein. Thus, e.g. four versions of the ®broblast growth factor-2 (FGF-2, or basic FGF) are synthesized due to initiation at three upstream CUG codons, in addition to initiation at an AUG codon (Florkiewicz and Sommer, 1989) . Translation at the CUG codons is activated in transformed and stressed cells (Vagner et al., 1996) . The N-terminally extended forms are translocated to the nucleus, while the AUG-initiated form remains cytoplasmic and is slowly released from the cell via a nonclassical, as yet unknown, pathway (Bugler et al., 1991; Cao and Pettersson, 1993) . Another example of a CUG-initiated protein is ®broblast growth factor 3 (FGF3, or Int-2). This protein is initiated in similar proportions either at an AUG, which gives rise to a protein secreted out of the cell via the normal exocytic pathway, or at an upstream CUG, resulting in an extended isoform that is translocated to the cell nucleus and nucleolus due to complex internal nuclear/nucleolar localization signals (Acland et al., 1990; Antoine et al., 1997; Kiefer et al., 1994) .
In light of these and other examples, it seemed plausible that p15.5 and p15 also could have dierent functions or cellular distributions. However, our , U251MG cells were transiently transfected with the constructs pCR-P15, pCR-P15:2, or pCRP15:4. At 48 h posttransfection, cells were incubated in 50 mM bromodeoxyuridine for 6 h, ®xed in 3% paraformaldehyde and incubated for 15 min in 1.5 M HC1. Cells were then double-stained with the polyclonal antiserum against p15 or a monoclonal antibody against BrdUrd (Ab-2, Calbiochem) using FITC-conjugated anti-rabbit IgG or TRITC-conjugated anti-mouse IgG (Sigma), respectively, as secondary antibodies. The fraction of positive cells were counted independently by two individuals using an Axiophot microscope (Zeiss) equipped for immuno¯uorescence. The table shows the results of three separate experiments Figure 3 Senescence-associated changes in U251MG cells expressing p15 or p15.5. U251MG glioma cells were transfected with pCR-P15 (a,b), pCR-P15:2 (c,d) or pCR-P15:4 (e,f) using Lipofectamine TM . Triton X-100-permeabilized (0.1%) and paraformaldehyde-®xed (3%) cells were analysed 10 days later either by indirect immuno¯uorescence (a,c,e,g) using the polyclonal p15 antiserum, and as secondary antibody FITC-conjugated antirabbit IgG (Sigma Immunochemicals, St Louis, MO, USA), or subjected to SA-b-gal staining (b,d,f,h) (Dimri et al., 1995) . Mocktransfected cells (g,h) served as controls. Cells were viewed in a Nikon Eclipse TE300 microscope, equipped with a Spot CCD camera (Diagnostic Instruments, Inc.). Bar=50 mm analyses showed no dierence in the capacity of the two forms to bind to CDK4 and CDK6, to inhibit DNA synthesis, nor to induce a replicative senescent phenotype. In addition, we also found that the stability, and intracellular distribution of the two isoforms were identical (data not shown). We therefore conclude that p15.5 and p15, are likely to be functionally indistinguishable. However, since we have only used a limited set of assays, it is still possible that the two isoforms may display functional dierences in some other assays. It is noteworthy that the GTG initiation codon is absent from the mouse p15 gene, while the other alternative initiation codon (ACG) has been conserved in frame with the ®rst AUG (Quelle et al., 1995) . The amino acid sequence that would be generated from this codon is, however, poorly conserved between mouse and man, suggesting that the 13 extra residues in human p15.5 may not be important for its function.
Finally, it may be relevant to mention a rare case of hereditary melanoma where the N-terminus of p16 is extended by eight residues due to a 24 bp insertion. This insertion duplicates the ®rst eight amino acids of the p16 N-terminus. The extended form (164 residues) was found to bind equally well to CDK4 and 6 as wildtype p16 (156 residues) (Parry and Monzon et al., 1998) . Thus, it is still unclear how the extended form predisposes to melanoma.
